Abstract
This study aims to assess the associations of serum and red blood cell (RBC) folate with cardiovascular and all-cause mortality in hypertensive adults. Data on serum and RBC folate from the 1999–2014 National Health and Nutrition Examination Survey were included. Through December 31, 2015, cardiovascular and all-cause mortality were identified from the National Death Index. Multiple Cox regression and restricted cubic spline analyses were used to determine the relationship between folate concentrations and outcomes. A total of 13,986 hypertensive adults were included in the analysis (mean age, 58.5 ± 16.1 years; 6898 [49.3%] men). At a median of 7.0 years of follow-up, 548 cardiovascular deaths and 2726 all-cause deaths were identified. After multivariable adjustment, the fourth quartile of serum folate was associated with cardiovascular (HR = 1.32 [1.02–1.70]) and all-cause (HR = 1.20 [1.07–1.35]) mortality compared to the second quartile, whereas the first quartile was only linked with increased all-cause (HR = 1.29 [1.15–1.46]) mortality. The inflection points for the non-linear associations of serum folate with cardiovascular and all-cause mortality were 12.3 ng/mL and 20.5 ng/mL, respectively. In addition, the highest quartile of RBC folate was associated with cardiovascular (HR = 1.68 [1.30–2.16]) and all-cause (HR = 1.30 [1.16–1.46]) mortality compared to the second quartile, but the lowest quartile was not associated with either outcome. The inflection points for the non-linear associations of RBC folate with cardiovascular and all-cause mortality were 819.7 and 760.1 ng/mL, respectively. The findings suggest non-linear associations between serum and RBC folate levels and the risk of cardiovascular and all-cause mortality in hypertensive adults.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. 2020;38:982–1004. https://doi.org/10.1097/HJH.0000000000002453.
Dinh QN, Drummond GR, Sobey CG, Chrissobolis S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int. 2014;2014:406960. https://doi.org/10.1155/2014/406960.
He S, Stein AD. Early-life nutrition interventions and associated long-term cardiometabolic outcomes: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr. 2021;12:461–89. https://doi.org/10.1093/advances/nmaa107.
Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. BMJ. 2014;349:g5226. https://doi.org/10.1136/bmj.g5226.
Ducker GS, Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metab. 2017;25:27–42. https://doi.org/10.1016/j.cmet.2016.08.009.
Burgess K, Bennett C, Mosnier H, Kwatra N, Bethel F, Jadavji NM. The antioxidant role of one-carbon metabolism on stroke. Antioxidants (Basel). 2020;9:1141. https://doi.org/10.3390/antiox9111141.
Armitage JM, Bowman L, Clarke RJ, Wallendszus K, Bulbulia R, Rahimi K, et al. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA. 2010;303:2486–94. https://doi.org/10.1001/jama.2010.840.
Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA. 2002;288:973–9. https://doi.org/10.1001/jama.288.8.973.
Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149–55. https://doi.org/10.1056/nejm199104253241701.
Zhang SM, Cook NR, Albert CM, Gaziano JM, Buring JE, Manson JE. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA. 2008;300:2012–21. https://doi.org/10.1001/jama.2008.555.
Jenkins DJA, Spence JD, Giovannucci EL, Kim YI, Josse R, Vieth R, et al. Supplemental vitamins and minerals for CVD prevention and treatment. J Am Coll Cardiol. 2018;71:2570–84. https://doi.org/10.1016/j.jacc.2018.04.020.
Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567–77. https://doi.org/10.1056/NEJMoa060900.
Kwok T, Lee J, Ma RC, Wong SY, Kung K, Lam A, et al. A randomized placebo controlled trial of vitamin B(12) supplementation to prevent cognitive decline in older diabetic people with borderline low serum vitamin B(12). Clin Nutr. 2017;36:1509–15. https://doi.org/10.1016/j.clnu.2016.10.018.
Rutjes AW, Denton DA, Di Nisio M, Chong LY, Abraham RP, Al-Assaf AS, et al. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life. Cochrane Database Syst Rev. 2018;12:Cd011906. https://doi.org/10.1002/14651858.CD011906.pub2.
Rautiainen S, Gaziano JM, Christen WG, Bubes V, Kotler G, Glynn RJ, et al. Effect of baseline nutritional status on long-term multivitamin use and cardiovascular disease risk: a secondary analysis of the Physicians’ Health Study II Randomized Clinical Trial. JAMA Cardiol. 2017;2:617–25. https://doi.org/10.1001/jamacardio.2017.0176.
Bostom AG, Carpenter MA, Kusek JW, Levey AS, Hunsicker L, Pfeffer MA, et al. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation. 2011;123:1763–70. https://doi.org/10.1161/circulationaha.110.000588.
Ebbing M, Bønaa KH, Nygård O, Arnesen E, Ueland PM, Nordrehaug JE, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA. 2009;302:2119–26. https://doi.org/10.1001/jama.2009.1622.
Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med. 1999;131:363–75. https://doi.org/10.7326/0003-4819-131-5-199909070-00008.
Peng Y, Dong B, Wang Z. Serum folate concentrations and all-cause, cardiovascular disease and cancer mortality: a cohort study based on 1999-2010 National Health and Nutrition Examination Survey (NHANES). Int J Cardiol. 2016;219:136–42. https://doi.org/10.1016/j.ijcard.2016.06.024.
Chen S, Honda T, Hata J, Sakata S, Furuta Y, Yoshida D, et al. High serum folate concentrations are associated with decreased risk of mortality among Japanese Adults. J Nutr. 2021;151:657–65. https://doi.org/10.1093/jn/nxaa382.
Liu M, Zhang Z, Zhou C, Li Q, He P, Zhang Y, et al. Relationship of several serum folate forms with the risk of mortality: a prospective cohort study. Clin Nutr. 2021;40:4255–62. https://doi.org/10.1016/j.clnu.2021.01.025.
Ford ES, Byers TE, Giles WH. Serum folate and chronic disease risk: findings from a cohort of United States adults. Int J Epidemiol. 1998;27:592–8. https://doi.org/10.1093/ije/27.4.592.
Kyte B, Ifebi E, Shrestha S, Charles S, Liu F, Zhang J. High red blood cell folate is associated with an increased risk of death among adults with diabetes, a 15-year follow-up of a national cohort. Nutr Metab Cardiovasc Dis. 2015;25:997–1006. https://doi.org/10.1016/j.numecd.2015.08.007.
Liu Y, Geng T, Wan Z, Lu Q, Zhang X, Qiu Z, et al. Associations of serum folate and vitamin B12 levels with cardiovascular disease mortality among patients with type 2 diabetes. JAMA Netw Open. 2022;5:e2146124. https://doi.org/10.1001/jamanetworkopen.2021.46124.
Xiong H, Li X, Cheng S, Chen P, Guo S, Huang X, et al. Folate status and mortality in US adults with diabetes: a nationally representative cohort study. Front Cardiovasc Med. 2022;9:802247. https://doi.org/10.3389/fcvm.2022.802247.
Gopinath B, Flood VM, Rochtchina E, Thiagalingam A, Mitchell P. Serum homocysteine and folate but not vitamin B12 are predictors of CHD mortality in older adults. Eur J Prev Cardiol. 2012;19:1420–9. https://doi.org/10.1177/1741826711424568.
Rotstein A, Kodesh A, Goldberg Y, Reichenberg A, Levine SZ. Serum folate deficiency and the risks of dementia and all-cause mortality: a national study of old age. Evid Based Ment Health. 2022;25:63–68. https://doi.org/10.1136/ebmental-2021-300309.
Yan LJ, Zhang FR, Zeng YR, Zheng Y. Serum folate and all-cause mortality is of non-linear relationship among population with chronic kidney disease: a retrospective cohort study. Int J Gen Med. 2021;14:2695–702. https://doi.org/10.2147/ijgm.S314904.
Soohoo M, Ahmadi SF, Qader H, Streja E, Obi Y, Moradi H, et al. Association of serum vitamin B12 and folate with mortality in incident hemodialysis patients. Nephrol Dial Transplant. 2017;32:1024–32. https://doi.org/10.1093/ndt/gfw090.
Sonawane K, Zhu Y, Chan W, Aguilar D, Deshmukh AA, Suarez-Almazor ME. Association of serum folate levels with cardiovascular mortality among adults with rheumatoid arthritis. JAMA Netw Open. 2020;3:e200100. https://doi.org/10.1001/jamanetworkopen.2020.0100.
Li Y, Qin X, Luo L, Wang B, Huo Y, Hou FF, et al. Folic acid therapy reduces the risk of mortality associated with heavy proteinuria among hypertensive patients. J Hypertens. 2017;35:1302–9. https://doi.org/10.1097/hjh.0000000000001292.
Huo Y, Li J, Qin X, Huang Y, Wang X, Gottesman RF, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA. 2015;313:1325–35. https://doi.org/10.1001/jama.2015.2274.
Zhou L, Huang H, Wen X, Chen Y, Liao J, Chen F, et al. Associations of serum and red blood cell folate with all-cause and cardiovascular mortality among hypertensive patients with elevated homocysteine. Front Nutr. 2022;9:849561. https://doi.org/10.3389/fnut.2022.849561.
Nkemjika S, Ifebi E, Cowan LT, Chun-Hai Fung I, Twum F, Liu F, et al. Association between serum folate and cardiovascular deaths among adults with hypertension. Eur J Clin Nutr. 2020;74:970–8. https://doi.org/10.1038/s41430-019-0533-7.
Twum F, Morte N, Wei Y, Nkemjika S, Liu F, Zhang J. Red blood cell folate and cardiovascular deaths among hypertensive adults, an 18-year follow-up of a national cohort. Hypertens Res. 2020;43:938–47. https://doi.org/10.1038/s41440-020-0482-5.
Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health. 1987;77:1435–8. https://doi.org/10.2105/ajph.77.11.1435.
Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995;273:402–7. https://doi.org/10.1001/jama.273.5.402.
Yang Q, Cogswell ME, Hamner HC, Carriquiry A, Bailey LB, Pfeiffer CM, et al. Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2006. Am J Clin Nutr. 2010;91:64–72. https://doi.org/10.3945/ajcn.2009.28401.
Wu A, Chanarin I, Slavin G, Levi AJ. Folate deficiency in the alcoholic–its relationship to clinical and haematological abnormalities, liver disease and folate stores. Br J Haematol. 1975;29:469–78. https://doi.org/10.1111/j.1365-2141.1975.tb01844.x.
Ebly EM, Schaefer JP, Campbell NR, Hogan DB. Folate status, vascular disease and cognition in elderly Canadians. Age Ageing. 1998;27:485–91. https://doi.org/10.1093/ageing/27.4.485.
Dangour AD, Breeze E, Clarke R, Shetty PS, Uauy R, Fletcher AE. Plasma homocysteine, but not folate or vitamin B-12, predicts mortality in older people in the United Kingdom. J Nutr. 2008;138:1121–8. https://doi.org/10.1093/jn/138.6.1121.
Duthie SJ, Narayanan S, Blum S, Pirie L, Brand GM. Folate deficiency in vitro induces uracil misincorporation and DNA hypomethylation and inhibits DNA excision repair in immortalized normal human colon epithelial cells. Nutr Cancer. 2000;37:245–51. https://doi.org/10.1207/s15327914nc372_18.
Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr. 2007;85:193–200. https://doi.org/10.1093/ajcn/85.1.193.
Troen AM, Mitchell B, Sorensen B, Wener MH, Johnston A, Wood B, et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr. 2006;136:189–94. https://doi.org/10.1093/jn/136.1.189.
Zitti B, Bryceson YT. Natural killer cells in inflammation and autoimmunity. Cytokine Growth Factor Rev. 2018;42:37–46. https://doi.org/10.1016/j.cytogfr.2018.08.001.
Knorr M, Münzel T, Wenzel P. Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction. Front Physiol. 2014;5:295 https://doi.org/10.3389/fphys.2014.00295.
Ong S, Rose NR, Čiháková D. Natural killer cells in inflammatory heart disease. Clin Immunol. 2017;175:26–33. https://doi.org/10.1016/j.clim.2016.11.010.
Acknowledgements
We appreciate the people who contributed to the NHANES data we studied.
Funding
This work was supported by the Science and Technology Talents Support Program of Shaanxi Provincial People’s Hospital (No. 2021BJ-10, No. 2021LJ-03, No. 2021JY-18). Science and technology development incubation fund of Shaanxi Provincial People’s Hospital (2022YJY-06, 2021YJY-08). Health research project of Shaanxi Province (2022B004).
Author information
Authors and Affiliations
Contributions
YX, JW and LZ designed the research, and had primary responsibility for the final content, JX and XZ conducted analyses and wrote the first draft of the paper. JX, XZ, GG, YZ, and RH revised the manuscript, and all authors read and approved the final manuscript and approved the final submitted version.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xu, J., Zhu, X., Guan, G. et al. Non-linear associations of serum and red blood cell folate with risk of cardiovascular and all-cause mortality in hypertensive adults. Hypertens Res 46, 1504–1515 (2023). https://doi.org/10.1038/s41440-023-01249-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-023-01249-3
Keywords
This article is cited by
-
Folate and cardiovascular disease
Hypertension Research (2023)